Company Email Format Management

AdaptVac

Biotechnology Research Horsholm, Hovedstaden, Dk 11 employees FIRST

Employees: 11
Contacts: 3
Emails: 3
Phones: 1

adaptvac.com LinkedIn Crunchbase

AdaptVac Overview

Headquarters: Horsholm, Hovedstaden, Dk
Phone Number: Available in AeroLeads
Website: adaptvac.com
Industry: Biotechnology Research
Employees: 11
Founded: 2017
Stock Symbol: FIRST
Funding: 12.4M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

in proprietary Virus-Like Particle (VLP) technology makes us a strong and versatile player in the field of new vaccines and immune therapy.

About AdaptVac

AdaptVac is a joint-venture between NASDAQ First North listed ExpreS2ion Biotech and University of Copenhagen spin-out NextGen Vaccines. The goal of the Joint Venture is to create a world class unit for the development of highly competitive vaccines and therapeutics against infectious diseases, cancer, and immunological disorders. The combination of ExpreS2ion’s proprietary insect cell expression technology, ExpreS2, and NextGen’s unique expertise in proprietary Virus-Like Particle (VLP) technology makes us a strong and versatile player in the field of new vaccines and immune therapy.

AdaptVac Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 1; 25.0% coverage

AdaptVac Org Chart

Sample employees and titles

Name	Title	Location	Contact
Ali Salanti	Professor at Ucph, Founder and CEO	Copenhagen, Capital Region of Denmark, Denmark	Email
Adam Sander Bertelsen	Chief Science Officer at Adaptvac	Copenhagen, Capital Region of Denmark, Denmark	View
Wian De Jongh	CEO at Adaptvac	Copenhagen, Capital Region of Denmark, Denmark	Email
Allan Rosetzsky		Hørsholm, Capital Region of Denmark, Denmark	Email Phone